Tscan Therapeutics Inc is trading 4.5% up at $0.95 as part of a broad risk-on rally triggered by a tentative U.S.–Iran peace agreement.
- The stock bounced from its previous close of $0.91 as market sentiment shifts toward riskier assets.
- The geopolitical breakthrough has helped ease global inflation concerns and boosted equity indices.
- The price movement is attributed to macroeconomic factors rather than company-specific news.